To investigate the efficacy and safety of allogeneic hematopoietic stem cell transplantation(allo-HSCT)for the treatment of BCR::ABL-negative chronic neutrophilic leukemia(CNL)and MDS/MPN with neutrophilia. This evidence concerns the gene BCR and myeloproliferative neoplasm.